A new simulator can accurately model COVID-19 and the effects of different mitigation strategies, which researchers say could help guide new policies to combat the pandemic.
The first COVID-19 vaccines are here, but challenges remain
Whilst vaccines against COVID-19 show there is light at the end of the tunnel, three main challenges still need to be addressed.
A new biosensor detects COVID-19 antibodies in 10-12 seconds
The testing platform identifies the presence of two antibodies in microliter samples of blood.
Oxford–AstraZeneca COVID-19 vaccine shown to be safe and effective
The results of the company’s COVID-19 vaccine clinical trials are the first to be published in a peer-reviewed journal.
Pfizer/BioNTech vaccine approved in the UK for immediate emergency use
The companies announce the first emergency approval of their mRNA vaccine against COVID-19, with rollout to begin next week.
Moderna’s COVID-19 vaccine shows 95% efficacy
US company second to report impressive efficacy for its COVID-19 vaccine candidate.
Trial COVID-19 vaccine shown to be 90% effective
Pfizer and BioNTech announce vaccine candidate against COVID-19 achieved success in first interim analysis from Phase 3 study.
Coronaviruses mimic immune proteins and hide in plain sight
New study finds coronaviruses are masters of mimicry, reproducing their host’s immune proteins to remain invisible and help promote infection.
Lipid nanoparticles boost potential vaccine against SARS-CoV-2
Researchers enhance the immune response against the receptor binding domain of SARS-CoV-2 by presenting it on liposomes, providing a promising strategy for vaccine development targeting this domain.
New test captures elusive blood biomarker to help identify severe COVID-19 before symptom onset
An inventive new approach lowers the limit of detection for a common assay, allowing researchers to identify elusive biomarkers in complex fluids, like the blood.